M. tuberculosis antigens

Details M. tuberculosis antigens M. tuberculosis antigens

2006-01-31

2006-01-31

Swartz, Rodney P (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

C424S184100, C424S185100, C424S192100, C424S234100, C530S300000, C530S350000

Reexamination Certificate

active

06991797

ABSTRACT:
The present invention is based on the identification and characterization of a number of novelM. tuberculosisderived proteins and protein fragments. The invention is directed to the polypeptides and immunologically active fragments thereof, the genes encoding them, immunological compositions such as vaccines and skin test reagents containing the polypeptides.

REFERENCES:
patent: 4683578 (1987-07-01), Betts et al.
patent: 4891315 (1990-01-01), Watson et al.
patent: 4952395 (1990-08-01), Shinnick et al.
patent: 4976958 (1990-12-01), Shinnick et al.
patent: 5026546 (1991-06-01), Hilgers et al.
patent: 5330754 (1994-07-01), Kapoor et al.
patent: 5559011 (1996-09-01), Kapoor et al.
patent: 5955077 (1999-09-01), Andersen et al.
patent: 195 40 250 (1997-02-01), None
patent: 0 729 250 (1996-08-01), None
patent: 0 734 132 (1996-09-01), None
patent: 0 869 649 (1998-10-01), None
patent: WO 92 14823 (1992-09-01), None
patent: WO 95/01441 (1995-01-01), None
patent: WO 96/37219 (1996-11-01), None
patent: WO 97/09428 (1997-03-01), None
patent: WO 97/09429 (1997-03-01), None
patent: 98/16645 (1998-04-01), None
patent: 98/16646 (1998-04-01), None
patent: WO 98 44119 (1998-10-01), None
patent: WO 98 53075 (1998-11-01), None
patent: WO 98 53076 (1998-11-01), None
Borodovsky et al., Computers Chem., vol. 17, pp. 123-133.
Brown, EMBL Sequence database.
Harboe et al., Infect. Immun. vol. 64, pp. 16-22.
Von Heijne et al., J. Mol. Biol., vol. 173, pp. 243-251.
Hochstrasser et al., Annal Biochem., vol. 173, pp. 424-435.
Kohler et al., Nature, vol. 256, pp. 495-497.
Li et al., Infect. Immun., vol. 61, pp. 1730-1734.
Lindblad et al., Infect. Immun., vol. 65, pp. 623-629.
Mahairs et al., J. Bacteriol., vol. 178, pp. 1274-1282.
Nagai et al., Infect. Immun., vol. 59, pp. 372-382.
Oettinger et al., Infect. Immun., vol. 62, pp. 2058-2064.
Ohara et al., Scand. J. Immunol., vol. 41, pp. 433-442.
Pal et al., Infect. Immun., vol. 60, pp. 4781-4792.
Pearson et al., Proc. Natl. Acad. Sci., USA, vol. 85, pp. 2444-2448.
Ploug et al., Anal Biochem., vol. 181, pp. 33-39.
Porath et al., FEBS Lett., vol. 185, pp. 306-310.
Roberts et al., Immunol., vol. 85, pp. 502-508.
Rosenkrands et al., Infect. Immun., vol. 66, No. 6, pp. 2728-2735.
Andersen et al., J. Immunol. vol. 154, pp. 3359-3372.
Rosenkrands et al., EMBL: Y12820.
Sorensen et al., Infect. Immun., vol. 63, pp. 1710-1717.
Theisen et al., Clinical and Diagnostic Laboratory Immunology, vol. 2, pp. 30-34.
Valdes-Stauber et al., Appl. Environ. Microbiol., vol. 60, pp. 3809-3814.
Valdes-Stauber et al., Appl. Environ. Microbiol., vol. 62, No. 4, pp. 1283-1286.
Williams, Science, 272:27.
Young et al., Proc. Natl. Acad. Sci. USA, vol. 82, pp. 2583-2587.
Crabtree et al., EMBL Sequence database.
Van Dyke et al., Gene, pp. 99-104.
Gosselin et al., J. Immunol., vol. 149, pp. 3477-3481.
XP002092185 EMBL Sequence.
Andersen et al., J. Immunol. Methods, vol. 161, pp. 29-39.
Andersen et al., Infect. Immun., vol. 60, pp. 2317-2323.
Rosenkrands et al., EMBL: 007812.
Wiegeshaus, E.H., et al. “Evaluation of the Protective Protency of New Tuberculosis Vaccines”, Reviews of Infectious Diseases, vol. 11, supplement 2, pp. S484-S490, Mar. 1989.
Orme, I.M., “New Vaccines against Tuberculosis”, Infectious Disease Clinic of North America, vol. 13, No. 1, pp. 169-185, Mar. 1999.
Andersen, Infect. Immun. vol. 62, pp. 2536-2544.
Barkholt et al., Anal. Biochem., vol. 177, pp. 318-322.
Scandinavian Journal of Immunology vol. 36, 1992 pp. 823-831 P. Andersen et al. ‘Identification of immunodominant antigens during infection withMycobacterium tuberculosis’.
Infection and Immunity vol. 61, No. 3, Mar. 1993, Washington US pp. 844-851 Peter Andersen et al. ‘Specificity of a protective memory immune response againstMycobacterium tuberculosis’.
Infection and Immunity vol. 59, No. 4, Apr. 1991, Washington US pp. 1558-1563 Peter Andersen et al. ‘T-cell proliferative response to antigens secreted byMycobacterium tuberculosis’ cited in the application.
Infection and Immunity vol. 60, No. 7, Jul. 1992, Washington US pp. 2880-2886 Kris Huygen et al. ‘Spleen cell cytokine secretion inMycobacterium bovisBCG-infected mice’.
Infection and Immunity vol. 59, No. 6, Jun. 1991, Washington US pp. 1905-1910 Peter Andersen et al. ‘Proteins released fromMycobacterium tuberculosisduring growth’ cited in the application.
Infection and Immunity vol. 56, No. 12, Dec. 1988, Washington US pp. 3046-3051 Christiane Abou-Zeid et al. ‘Characterization of fibronectin-binding antigens released byMycobacterium toberculosisandMycobacterium bovisBCG’.
Infection and Immunity vol. 57, No. 10, Oct. 1989, Washington US pp. 3123-3130 Martine Borremans et al. ‘Cloning sequence determination, and expression of a 32-kilodalton-protein gene ofMycobacterium tuberculosis’.
Infection and Immunity vol. 62, No. 6, Jun. 1994, Washington US pp. 2536-2544 Peter Andersen ‘Effective vaccination of mice againstMycobacterium tuberculosisinfection with a soluble mixture of secreted mycobacterial proteins’.
Moriyama S et al.: “Digital Transmission of High Bit Rate Signals Using 16DAPSK-OFDM Modulation Scheme” IEEE Transactions on Broadcasting, Mar. 1998, vol. 44, No. 1, pp. 115-122, XP002105431.
Man et al. “Treatment of human muscle creatine kinase with glutaraldehyde preferentially increases the immunogenicity of the native conformation and permits production of high-affinity monoclonal antibodies which recognize two distinct surface epitopes”, J, Oct. 1, 1989.
A.B. Andersen et al., MPB64 Possesses Tuberculosis-Complex′-Specific B- and T-Cell Epitopes, Scand J. Immunol 34, 365-372, 1991.
Anne Worsaee et al., Allergenic and Blastogenic Reactivity of Three Antigens fromMycobacterium tuberculosisin Sensitized Guinea Pigs, Infection and Immunity, Dec. 1987, p 2922-2927.
Yamaguchi Ryugi, et al. “Cloning and Characterization of the Gene for immunogenic Protein MPB64 ofMycobacterium bovisBCG” Infection and Immunity 57(1):283-288 (1989).
Wiker, H.G., et al., “A Family of Cross-Reacting Proteins Secreted byMycobacterium tuberculosis”, Scand J. Immunol. 36:307-319 (1992).
Leao, S.C., “Tuberculosis: New Strategies for the Development of Diagnostic Tests and Vaccines”, Brazilian J. Med. Biol. Res. 26:827-833 (1993).
Oettiner, Thomas, et al., “Cloning and B-Cell-Epitope Mapping of MPT64 fromMycobacterium tuberculosisH37Rv”, Infection and Immunity 62(5):2058-2064 (1994).
Boswell et al. Computational Molecular Biology, Oxford University Press, pp. 161-178, 1988.
Flesch and Kaufmann, Mycobacterial Growth Inhibition by Interferon-y-Activated Bone Marrow Macrophages and Differential . . . tuberculosis, The Journal of Immunology, vol. 138, No. 12, pp. 4408-4413, Jun. 15, 1987.
Lefford and McGregor, Immunological Memory in Tuberculosis, Cellular Immunology, vol. 14, pp. 417-428, 1974.
Orme, Characteristics and Specificity of Acquired Immunologic Memory toMycobacterium tuberculosisInfection The Journal of Immunology, vol. 140, No. 10, pp. 3589-3593, May 15, 1988.
G.A.W. Rock, The Role of Activated Macrophages in protection and immunopathology in Tuberculosis, Research in Microbiology vol. 141, No. 2, Feb. 1990, pp. 253-256.
Sanger, Nicklen and Coulson, DNA Sequencing with Chain-Terminating Inhibitors, Proc. Natl. Acad. Sci USA, vol. 74, No. 12, pp. 5463-5467, Dec. 1977.
Andersen, P. et al., Jun. 1991, Proteins released fromMycobacterium Tuberculosisduring growth, Infect. Immun. 59(6): 1905-1910.
Baldwin, S.L. et al., Jun. 1998, Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis, Infect. Immun. 66(6):2951-2959.
Boesen, H. et al., Apr. 1995, Human T-cell responses to secreted antigen fractions ofMycobacterium tuberculosis, Infect. Immun. 63(4): 1491-1497.
Brandt et al., 1996, Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity toMycobacterium tuberculosis, J. Immunol. 157:3527-3533.
Br

Affiliated with

Also associated with

Rating

M. tuberculosis antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with M. tuberculosis antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and M. tuberculosis antigens will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3552074